Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
18.78
-0.84 (-4.28%)
Apr 3, 2025, 2:45 PM CST
SHE:002755 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
Net Income | 163.14 | -148.53 | -225.83 | 379.91 | 721.63 | 780.96 | Upgrade
|
Depreciation & Amortization | 84.62 | 84.62 | 92.19 | 94.51 | 92.62 | 87.99 | Upgrade
|
Other Amortization | 4.93 | 4.93 | 5.67 | 4.15 | 1.95 | 0.81 | Upgrade
|
Loss (Gain) From Sale of Assets | -0.03 | -0.03 | -0.21 | -0.3 | 0.02 | 2.32 | Upgrade
|
Asset Writedown & Restructuring Costs | 5.7 | 5.7 | 1.09 | 0.86 | 0.26 | 1.24 | Upgrade
|
Loss (Gain) From Sale of Investments | -26.89 | -26.89 | -29.72 | -20.68 | -7.28 | -1.19 | Upgrade
|
Provision & Write-off of Bad Debts | -4.48 | -4.48 | -7.02 | -4.51 | -8.38 | - | Upgrade
|
Other Operating Activities | 92.76 | -52.51 | -13.44 | 4.75 | 8.51 | -1.03 | Upgrade
|
Change in Accounts Receivable | 53.45 | 53.45 | 262.97 | 363.45 | 110.98 | -346.72 | Upgrade
|
Change in Inventory | -26.41 | -26.41 | -1.79 | 26.89 | 57.82 | -46.09 | Upgrade
|
Change in Accounts Payable | 93.18 | 93.18 | -133.44 | -281.03 | -393.7 | 48.22 | Upgrade
|
Change in Other Net Operating Assets | -7.34 | -7.34 | -3.61 | 1.92 | 1.83 | 11.58 | Upgrade
|
Operating Cash Flow | 430.38 | -26.57 | -52.81 | 567.71 | 580.38 | 534.62 | Upgrade
|
Operating Cash Flow Growth | - | - | - | -2.18% | 8.56% | 7.53% | Upgrade
|
Capital Expenditures | -153.57 | -129.32 | -150.45 | -133.76 | -199.68 | -169.02 | Upgrade
|
Sale of Property, Plant & Equipment | 0.81 | 0.59 | 0.88 | 0.94 | 0.01 | 0.88 | Upgrade
|
Cash Acquisitions | - | - | - | - | - | -7.6 | Upgrade
|
Investment in Securities | -85 | 115 | -315 | -438 | -18 | -119.84 | Upgrade
|
Other Investing Activities | 24.39 | 25.29 | 25.65 | 7.79 | 1.93 | 1.19 | Upgrade
|
Investing Cash Flow | -213.37 | 11.56 | -438.92 | -563.02 | -215.74 | -294.38 | Upgrade
|
Short-Term Debt Issued | - | 154.72 | 45 | - | 22.44 | - | Upgrade
|
Total Debt Issued | 9.96 | 154.72 | 45 | - | 22.44 | - | Upgrade
|
Short-Term Debt Repaid | - | -65.72 | - | -20 | - | -8 | Upgrade
|
Long-Term Debt Repaid | - | -3.08 | -2.91 | -2.76 | - | - | Upgrade
|
Total Debt Repaid | -102.08 | -68.8 | -2.91 | -22.76 | - | -8 | Upgrade
|
Net Debt Issued (Repaid) | -92.12 | 85.92 | 42.09 | -22.76 | 22.44 | -8 | Upgrade
|
Issuance of Common Stock | 170.64 | 206.38 | 127.02 | 0.38 | - | 0.01 | Upgrade
|
Repurchase of Common Stock | - | - | - | -1.6 | -0.07 | - | Upgrade
|
Common Dividends Paid | -1 | -1.12 | -93.19 | -185.76 | -205.19 | -116.73 | Upgrade
|
Other Financing Activities | -0.28 | - | - | - | - | - | Upgrade
|
Financing Cash Flow | 77.24 | 291.17 | 75.91 | -209.74 | -182.82 | -124.72 | Upgrade
|
Foreign Exchange Rate Adjustments | 1.65 | -1.2 | 15.6 | -0.02 | -0.06 | 0.02 | Upgrade
|
Net Cash Flow | 295.89 | 274.97 | -400.22 | -205.07 | 181.76 | 115.53 | Upgrade
|
Free Cash Flow | 276.81 | -155.89 | -203.27 | 433.95 | 380.7 | 365.6 | Upgrade
|
Free Cash Flow Growth | - | - | - | 13.99% | 4.13% | -8.90% | Upgrade
|
Free Cash Flow Margin | 16.20% | -10.80% | -10.85% | 13.97% | 10.06% | 8.09% | Upgrade
|
Free Cash Flow Per Share | 0.30 | -0.17 | -0.22 | 0.47 | 0.41 | 0.39 | Upgrade
|
Cash Interest Paid | - | - | - | 0.27 | - | - | Upgrade
|
Cash Income Tax Paid | 174.44 | 136.72 | 208.09 | 433.1 | 499.23 | 597.46 | Upgrade
|
Levered Free Cash Flow | 111.59 | -83.12 | -101.11 | 263.79 | 112.12 | 98.23 | Upgrade
|
Unlevered Free Cash Flow | 113.21 | -81.37 | -99.38 | 266.28 | 113.96 | 98.26 | Upgrade
|
Change in Net Working Capital | -155.26 | -139.96 | -148.96 | -107.8 | 238.77 | 348.23 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.